californium has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowles, ND; Cosgrove, GE; Jernigan, MC; Satterfield, LC; Storer, JB; Ullrich, RL | 1 |
| Danigel, H; Dellbrügge, J; Jungclas, H; Pflüger, KH; Schmidt, L | 1 |
| Almond, PR; Castro, JR; Oliver, GD; Withers, HR | 1 |
3 other study(ies) available for californium and Lung Neoplasms
| Article | Year |
|---|---|
The influence of dose and dose rate on the incidence of neoplastic disease in RFM mice after neutron irradiation.
Topics: Animals; Californium; Cesium Radioisotopes; Dose-Response Relationship, Radiation; Eye Neoplasms; Female; Gamma Rays; Harderian Gland; Leukemia, Radiation-Induced; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Neutrons; Ovarian Neoplasms; Pituitary Neoplasms | 1976 |
Drug monitoring of etoposide (VP16-213). I. A combined method of liquid chromatography and mass spectrometry.
Topics: Californium; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Computers; Etoposide; Half-Life; Humans; Kinetics; Lung Neoplasms; Mass Spectrometry; Podophyllotoxin | 1985 |
Experience with californium 252 in clinical radiotherapy.
Topics: Aged; Californium; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cheek; Computers; Evaluation Studies as Topic; Female; Head and Neck Neoplasms; Humans; Lip Neoplasms; Lung Neoplasms; Male; Melanoma; Methods; Neoplasms; Pilot Projects; Protective Devices; Radiation Protection; Radiotherapy Dosage; Radium; Time Factors; Tongue Neoplasms; Uterine Cervical Neoplasms; Vaginal Neoplasms | 1973 |